Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00702065 · ClinicalTrials.gov registry record
A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
A clinical trial, sponsored by EMD Serono.
- Completed
- Registry status
- 599
- Enrollment target
NCT00702065: Completed study, sponsored by EMD Serono.
NCT00702065 is a clinical trial that has completed, run by EMD Serono. The registered enrollment target is 599 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00702065 has completed, sponsored by EMD Serono.
- COMPLETED
- Registry status
- 599 participants
- Enrollment target
Study Summary
This is a multi-center, multi-regional observational,24 month study. Health-related quality of life data from the MusiQoL instrument and SF-36 instrument will be collected at baseline, M6, M12, M18 and M24 in patients with MS. In addition, physical health outcomes such as expanded disability status scores (EDSS) will be collected every 6 months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 599 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-10 |
What the finished NCT00702065 record still lists
NCT00702065 is an observational study that tracks outcomes without assigning an intervention. The registered 599 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00702065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00702065 about?
NCT00702065 is a clinical study titled "A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment". This is a multi-center, multi-regional observational,24 month study. Health-related quality of life data from the MusiQoL instrument and SF-36 instrument will be collected at baseline, M6, M12, M18 and M24 in patients with MS. In addition, physical health outcomes such as expanded disability status...
What is the current status of trial NCT00702065?
This trial is currently completed. The enrollment target is 599 participants. The study started on 2007-11. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00702065?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia